Get the Daily Brief
Latest Biotech News
Royalty Pharma Buys Royalty on Amgen’s Small Cell Lung Cancer Drug
Royalty Pharma has acquired a royalty interest in Amgen's immunotherapy Imdelltra (tarlatamab-dlle), designed for extensive-stage small cell lung cancer (ES-SCLC), in a deal valued up to $950...
AI Identifies Antimicrobial Peptides in Venoms to Fight Drug Resistance
Researchers led by the University of Pennsylvania employed artificial intelligence to screen venom-derived peptides, discovering potent new antimicrobial compounds amid the pressing threat of...
FDA Urged to Accelerate Approvals for Rare Disease Treatments
An opinion piece emphasizes the necessity for the FDA to expedite regulatory pathways for therapies targeting rare diseases. The current pace of drug approvals is considered insufficient given the...
AI Model Personalizes Stroke Prevention in Atrial Fibrillation Patients
Mount Sinai researchers developed a Graph Neural Network-based AI that precisely identifies which patients with atrial fibrillation require anticoagulant therapy to prevent stroke. Leveraging...
Breakthrough in Brain-Computer Interface Using AI Co-Pilot
UCLA engineers created a wearable, noninvasive brain-computer interface enhanced by artificial intelligence acting as a co-pilot to decode user intent. This system facilitates control of assistive...
New Therapeutic Targets Emerging in Acute Myeloid Leukemia Resistance
Recent studies underscore the role of transcription factor Nrf2 and the emerging class of BH3 mimetics in overcoming chemoresistance in acute myeloid leukemia (AML). Nrf2 modulates cellular...
Climate Change Exacerbates Transboundary Water Conflicts Globally
A study published in Nature Communications quantitatively links climate change-driven surface water scarcity to increased transboundary conflicts. The research reveals how hydrological stress due...
Advances in Deep Learning Enhance Esophageal and Brain Tumor Diagnostics
Innovative AI frameworks demonstrate enhanced accuracy in cancer diagnostics through medical imaging analysis. The OncoMet deep learning system predicts esophageal cancer progression by decoding...
CRISPR and AI Empower Rapid Virus Detection and Genome Engineering
The convergence of CRISPR technology and artificial intelligence is accelerating viral pathogen detection and genome editing precision. A novel CRISPR-based assay enables rapid identification of...
Royalty Pharma Deal Boosts Lung Cancer Drug Market Outlook
Royalty Pharma's $950 million acquisition of a royalty interest in Amgen’s approved small cell lung cancer drug, Imdelltra, underlines expanding market confidence. Imdelltra employs bispecific...
Royalty Pharma Acquires Amgen’s Immunotherapy: $950 Million Deal
Royalty Pharma has secured a royalty interest in BeOne Medicines’ Imdelltra, an immunotherapy for extensive-stage small cell lung cancer, in a deal valued up to $950 million. Imdelltra, a...
AI Uncovers Antimicrobial Peptides in Venoms: A New Drug Source
Researchers from the University of Pennsylvania have employed artificial intelligence to identify novel antimicrobial compounds within venom proteins of snakes, spiders, and scorpions. These...
Pythia Model Advances Precision in CRISPR–Cas9 Genome Editing
A novel deep learning framework named Pythia promises to revolutionize precision gene editing by forecasting optimal repair templates for CRISPR–Cas9 applications. This method enhances editing...
Baxdrostat Phase 3 Filing Ahead After Hypertension Phase 3 Success
AstraZeneca’s candidate hypertension drug baxdrostat demonstrated approximately 10 mmHg blood pressure reductions in a pivotal phase 3 trial, setting the stage for imminent FDA submission. The...
Novel Therapeutics Targeting BTK and WEE1 in Cancer Treatment
Recent research introduces innovative compounds aimed at modulating Bruton’s tyrosine kinase (BTK) and WEE1 kinase, key regulators in cancer cell survival and proliferation. Shanghai Helioson...
Machine Learning Enhances Radiomics and Deep Learning for Cancer Prognosis
Innovative AI-driven methodologies are increasingly advancing oncology diagnostics and prognostics. Researchers have employed XGBoost models to differentiate primary brain tumors from metastases,...
Advances in Biomarkers and Cellular Mechanisms in Cancer and Reproductive Health
Recent studies have elucidated important molecular biomarkers and pathways impacting cancer and reproductive outcomes. Investigations highlight CBFA2T3 as a prognostic biomarker in lung...
Rapid Testing and AI in Healthcare: Fighting Resistance and Predicting Outcomes
The integration of rapid RT-PCR testing in outpatient settings emerges as a key tool in combating antibiotic resistance by reducing unnecessary prescriptions. Concurrently, AI innovations such as...
Innovations in Medical Devices and Monitoring Enhance Patient Care
Recent developments in biomedical engineering showcase milestones in device innovation, including handheld robotic-assisted guidance for ACL reconstruction, laser sensor technology for real-time...
Royalty Pharma Buys Amgen’s Lung Cancer Drug: $950 Million Deal
Royalty Pharma has acquired a royalty interest in Amgen’s immunotherapy Imdelltra, used for extensive-stage small cell lung cancer (ES-SCLC), in a deal worth up to $950 million. Imdelltra, a...